Crossref
GLP-1 and GIP Drugs Before Endoscopy May Raise Residual Gastric Volume Risk
JAMA · 28.04.2026 · 335 (16) · 1382
DOI: 10.1001/jama.2026.1035 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 28.04.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). GLP-1 and GIP Drugs Before Endoscopy May Raise Residual Gastric Volume Risk. JAMA, 335(16), 1382. https://doi.org/10.1001/jama.2026.1035
Vancouver
Anderer S. GLP-1 and GIP Drugs Before Endoscopy May Raise Residual Gastric Volume Risk. JAMA. 2026;335(16):1382. doi:10.1001/jama.2026.1035
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {GLP-1 and GIP Drugs Before Endoscopy May Raise Residual Gastric Volume Risk},
journal = {JAMA},
year = {2026},
volume = {335},
number = {16},
pages = {1382},
doi = {10.1001/jama.2026.1035}
}
EUVIMED